At a glance
ClinicalIndex Comparison RecordN/AUnknown· 1,000 target
Drug / intervention
Cap-assisted endoscopic sclerotherapy using long needle +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse: a Nationwide Multicenter Randomized Controlled Trial
The Second Hospital of Nanjing Medical University·interventional·Posted Apr 16, 2019·Updated Apr 2, 2024
In Brief
A clinical study evaluating Cap-assisted endoscopic sclerotherapy using long needle and Cap-assisted endoscopic sclerotherapy using short needle for Internal Hemorrhoid and Rectal Prolapse. Targeting 1,000 participants across 1 site.
Detailed Summary
This clinical trial aims to evaluate the efficacy and safety of long needle and short needle in the treatment of internal hemorrhoids and rectal prolapse through CAES (Cap-assisted endoscopic sclerotherapy).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInternal Hemorrhoid, Rectal Prolapse
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
2020202120222023202420252026
First PostedApr 2019
Enrollment StartJun 2019
Primary CompletionMar 2025
Study CompletionMar 2025
TodayJul 2026
First PostedApr 16, 2019
Enrollment StartJun 24, 2019
Primary CompletionMar 1, 2025
Study CompletionMar 27, 2025
TodayJul 1, 2026
Enrollment to primary: 5.7 yearsPosted 7.2 years ago
Interventions
Cap-assisted endoscopic sclerotherapy using long needleprocedure
Participants were treated with CAES using long needle.
Cap-assisted endoscopic sclerotherapy using short needleprocedure
Participants were treated with CAES using short needle.